(1)
Adjuvant Topical Dorzolamide or Timolol With Intravitreal Bevacizumab for Diabetic Macular Edema: A Double-Blind Randomized Controlled Trial. J Curr Biomed Rep 2024, 5 (1), 14-19. https://doi.org/10.61882/jcbior.5.1.279.